OpenFilings

Jazz Pharmaceuticals plc

Form10-Q

Report Period2023-09-30

Date Filed2023-11-08

Time Filed16:11:16

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATION OF INTERIM PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
CERTIFICATIONS OF CEO AND INTERIM PFO PURSUANT TO 18 U.S.C. SECTION 1350
Filing on SEC Edgar